BiomarkersHumans
Subjective Cognitive Decline and Minor Neuropsychological Deficits: Importance for Risk Stratification and Trial Recruitment in Early Alzheimer´s Disease
AAIC 2025 Abstract
Abstract
Background: The recruitment of participants with a high risk of decline is crucial for the success of clinical trials in the earliest phases of Alzheimer´s Disease (AD), where treatment benefits could be the largest.
The paper
Melina Stark, Elizabeth Kuhn, Michael Wagner, Luca Kleineidam
Show 15 more authors
Henning Boecker, Frederic Brosseron, Katharina Büerger, Marcel Daamen, Christoph Laske, Robert Perneczky, Oliver Peters, Josef Priller, Matthias Schmid, Anja Schneider, Annika E. Spottke, Stefan J. Teipel, Jens Wiltfang, Emrah Düzel, Frank Jessen,University of Bonn
AAIC 2025 Abstract · 25 Dec 2025 · CC BY
Presented at AAIC 2025
